Orchestra BioMed Holdings, Inc. Quarterly Depreciation in USD from Q1 2022 to Q4 2024

Taxonomy & unit
us-gaap: USD
Description
The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.
Summary
Orchestra BioMed Holdings, Inc. quarterly/annual Depreciation history and growth rate from Q1 2022 to Q4 2024.
  • Orchestra BioMed Holdings, Inc. Depreciation for the quarter ending December 31, 2024 was $84K, a 15.1% increase year-over-year.
  • Orchestra BioMed Holdings, Inc. Depreciation for the twelve months ending December 31, 2024 was $308K, a 7.32% increase year-over-year.
  • Orchestra BioMed Holdings, Inc. annual Depreciation for 2024 was $308K, a 7.32% increase from 2023.
  • Orchestra BioMed Holdings, Inc. annual Depreciation for 2023 was $287K, a 29.3% increase from 2022.
Depreciation, Trailing 12 Months (USD)
Depreciation, Quarterly (USD)
Depreciation, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q4 2024 $308K $84K +$11K +15.1% Oct 1, 2024 Dec 31, 2024 10-K 2025-03-31
Q3 2024 $297K $76K +$5K +7.04% Jul 1, 2024 Sep 30, 2024 10-Q 2024-11-12
Q2 2024 $292K $74K +$2K +2.78% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-12
Q1 2024 $290K $74K +$3K +4.23% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-13
Q4 2023 $287K $73K +$2K +2.82% Oct 1, 2023 Dec 31, 2023 10-K 2025-03-31
Q3 2023 $285K $71K +$17K +31.5% Jul 1, 2023 Sep 30, 2023 10-Q 2024-11-12
Q2 2023 $268K $72K +$23K +46.9% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-12
Q1 2023 $245K $71K +$23K +47.9% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-13
Q4 2022 $222K $71K Oct 1, 2022 Dec 31, 2022 10-K 2024-03-27
Q3 2022 $54K Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-13
Q2 2022 $49K Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-10
Q1 2022 $48K Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-12
* An asterisk sign (*) next to the value indicates that the value is likely invalid.